NCT03284320
Retrospective Study in Sarcoma Patients No drug interventions Not Available Not Available completed NCT02805725
Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide treatment 1 / 2 completed NCT02789384
CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study. No drug interventions other Not Available recruiting NCT06535997
Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE No drug interventions Not Available Not Available not_yet_recruiting NCT06308419
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions No drug interventions treatment 1 recruiting NCT03602833
Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma No drug interventions treatment 1 / 2 unknown_status NCT02787642
A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma treatment 1 completed NCT03242382
Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. treatment 2 recruiting NCT05741944
The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients No drug interventions supportive_care Not Available recruiting NCT02630368
A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) No drug interventions treatment 1 / 2 recruiting NCT01389050
High Precision RT For Soft-Tissue Sarcoma No drug interventions treatment 2 completed NCT01438554
Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma No drug interventions other 1 completed NCT03475953
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03007771
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia No drug interventions device_feasibility 1 withdrawn NCT02987959
Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas No drug interventions treatment 2 terminated NCT04181970
Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK No drug interventions Not Available Not Available recruiting NCT03175718
INPWT on Wound Complications & Clinical Outcomes After Lower Extremity Sarcoma Surgery Preop Radiation Therapy Patients No drug interventions treatment Not Available recruiting NCT03016819
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) No drug interventions treatment 3 active_not_recruiting NCT03096912
A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma No drug interventions treatment 2 unknown_status NCT01543802
Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma No drug interventions treatment 2 terminated NCT01594203
Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma No drug interventions Not Available Not Available unknown_status NCT05497843
Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS) No drug interventions treatment 2 active_not_recruiting NCT04318964
TAEST16001 in the Treatment of Soft Tissue Sarcoma No drug interventions treatment 1 active_not_recruiting NCT05301764
A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma No drug interventions treatment 1 / 2 recruiting NCT05111964
HIFU Ablation of Soft Tissue Sarcoma No drug interventions treatment Not Available recruiting NCT00629343
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide No drug interventions treatment 1 unknown_status NCT02192333
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors No drug interventions supportive_care Not Available completed NCT05761054
Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT) No drug interventions treatment Not Available recruiting NCT01575951
Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection No drug interventions screening Not Available completed NCT05539677
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research No drug interventions Not Available Not Available recruiting NCT02300545
Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy treatment 2 completed NCT05655598
TAS-116 Plus Palbociclib in Breast and Rb-null Cancer treatment 1 recruiting NCT03524898
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma treatment 1 / 2 terminated NCT06264505
Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study No drug interventions Not Available Not Available not_yet_recruiting NCT04040205
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration treatment 2 recruiting NCT05955105
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies treatment 1 / 2 recruiting NCT06526897
Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma No drug interventions diagnostic Not Available not_yet_recruiting NCT00087997
A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas treatment 2 completed NCT04733183
Efficacy and Safety of L19TNF in Previously Treated Patients With Advanced Stage or Metastatic Soft-tissue Sarcoma treatment 2 recruiting NCT05189483
Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma. treatment 2 recruiting NCT02267083
Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma treatment 2 completed NCT00998361
Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas No drug interventions treatment 2 unknown_status NCT02204111
Patient Directed Intervention to Improve the Quality of Life for Patients With Soft Tissue Sarcoma No drug interventions Not Available Not Available completed NCT02706171
Stereotactic Radiosurgery for Soft Tissue Sarcoma No drug interventions treatment Not Available withdrawn NCT00611078
Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study No drug interventions Not Available Not Available completed NCT02624388
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) supportive_care 2 terminated NCT03867188
Liposomal Bupivacaine (Exparel) in Sarcomas supportive_care 0 terminated NCT02584309
Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma treatment 2 completed NCT00102609
A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma treatment 1 completed NCT03345485
Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT01803152
Dendritic Cell Vaccine for Children and Adults With Sarcoma treatment 1 completed NCT02945800
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma treatment 2 active_not_recruiting NCT05926700
Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment No drug interventions treatment 2 recruiting NCT06022159
A Study to Evaluate Pre- or Post-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa. No drug interventions treatment 2 recruiting NCT03338959
Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma treatment 1 / 2 completed NCT01296659
Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma treatment 1 withdrawn NCT03520959
A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702) treatment 3 terminated NCT05051059
Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients No drug interventions other Not Available recruiting NCT04288375
Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs No drug interventions treatment 2 recruiting NCT01259375
Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma treatment 2 completed NCT03468075
Gemcitabine Plus Ascorbate for Sarcoma in Adults treatment 2 terminated NCT03792542
Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy treatment 2 unknown_status NCT02783599
A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma treatment 1 completed NCT02775799
National Swiss Sarcoma Cohort Study No drug interventions Not Available Not Available terminated NCT03913806
FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW diagnostic 1 / 2 completed NCT01299506
Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide No drug interventions Not Available Not Available completed NCT01458249
An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma (Study E7389-J081-217) treatment 2 completed NCT05944913
Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy No drug interventions other Not Available recruiting NCT05171413
Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue Sarcoma No drug interventions Not Available Not Available recruiting NCT05755113
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma treatment 2 recruiting NCT01812018
Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma treatment 2 unknown_status NCT03042819
Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas treatment 1 completed NCT02795819
Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer treatment 1 terminated NCT04589741
Toripalimab Combined With CAV/IE Regimen treatment 2 recruiting NCT04921917
Exercise and Soft Tissue Sarcoma No drug interventions treatment Not Available recruiting NCT01347034
Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) No drug interventions treatment 2 completed NCT03967834
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group No drug interventions other Not Available recruiting NCT05886634
A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma treatment 2 recruiting NCT03277924
Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas treatment 1 / 2 completed NCT06537596
89Zr-olaratumab Dosimetry in Participants With Soft Tissue Sarcoma diagnostic 1 not_yet_recruiting NCT03916796
Rehabilitation and Quality of Life Assessment for Soft Tissue Sarcoma Treated With Radiotherapy and Surgery No drug interventions supportive_care Not Available terminated NCT05328258
Use of GnRHa During Chemotherapy for Fertility Protection treatment 3 recruiting NCT02890758
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 treatment 1 completed NCT04969835
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours No drug interventions treatment 1 recruiting NCT01498835
Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma treatment 1 completed NCT02432963
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy treatment 1 active_not_recruiting NCT02982486
A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma treatment 2 unknown_status NCT00188422
Study of Low Dose CT in Sarcoma Patients No drug interventions diagnostic 1 completed NCT04776525
Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma treatment 2 recruiting NCT03085225
Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas. treatment 1 completed NCT04165330
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors treatment 1 / 2 active_not_recruiting NCT01382030
Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma No drug interventions treatment 2 completed NCT02632448
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer basic_science 1 / 2 recruiting NCT00525057
Dalteparin in Preventing DVT in Participants With Cancer No drug interventions prevention Not Available completed NCT04579757
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT04946357
Neoadjuvant Irradiation of Extremity Soft Tissue Sarcoma With Ions No drug interventions treatment Not Available recruiting NCT03508726
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas treatment 1 / 2 completed NCT05518526
Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary Metastases treatment 1 / 2 recruiting NCT01095926
Pharmacokinetic Study of Doxorubicin in Children With Cancer treatment 2 completed NCT03217266
Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma treatment 1 active_not_recruiting NCT01626066
Cathepsin Activatable Fluorescent Probe No drug interventions diagnostic 1 completed NCT04118166
Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma treatment 2 completed NCT06500065
68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas No drug interventions diagnostic Not Available recruiting NCT01904565
Hyperthermia and Proton Therapy in Unresectable Soft Tissue Sarcoma No drug interventions treatment 1 / 2 unknown_status NCT05596565
The Effects of Observer Presence and Type on Patients' Perception of Exercise in Patients With Soft Tissue Sarcoma No drug interventions treatment Not Available not_yet_recruiting NCT05938374
Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma treatment 2 recruiting NCT03244020
LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology prevention 4 enrolling_by_invitation NCT00580320
Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma No drug interventions treatment 1 completed NCT01427582
YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access Not Available Not Available no_longer_available NCT00876031
Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma treatment 3 completed NCT05142631
Fruquintinib in the Treatment of Soft Tissue Sarcoma treatment 2 unknown_status NCT05821231
Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma treatment 1 recruiting NCT04725331
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors treatment 1 / 2 recruiting NCT00931931
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors No drug interventions treatment 1 completed NCT05582031
Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers treatment 2 withdrawn NCT05420727
Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach treatment 1 completed NCT04634227
Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) No drug interventions treatment 0 recruiting NCT03994627
Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma Not Available Not Available available NCT06252727
Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES) treatment 1 withdrawn NCT04037527
Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities treatment 1 suspended NCT01696760
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology supportive_care Not Available completed NCT05000294
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types treatment 1 / 2 recruiting NCT05712694
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC) treatment 3 recruiting NCT05109494
Hypofractionated vs Conventional Fractionated RT in Soft Tissue Sarcomas No drug interventions treatment 2 recruiting NCT05950594
IVIM & OLINK in Sarcoma No drug interventions diagnostic 2 recruiting NCT03365791
PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies treatment 2 completed NCT05688280
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS No drug interventions treatment 1 / 2 recruiting NCT03116529
Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma No drug interventions treatment 1 / 2 active_not_recruiting NCT02571829
A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma treatment 2 unknown_status NCT00615329
Huntsman Biopsy Study No drug interventions Not Available Not Available terminated NCT00413192
E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma No drug interventions treatment 2 completed NCT06566092
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants No drug interventions treatment 1 recruiting NCT03899792
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors No drug interventions treatment 1 / 2 recruiting NCT04553744
Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma Surgeons No drug interventions Not Available Not Available withdrawn NCT03452644
US-Guided Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue Tumors No drug interventions Not Available Not Available completed NCT00288444
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer No drug interventions treatment 1 terminated NCT00541840
Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma No drug interventions treatment 1 / 2 unknown_status NCT05917301
Pre-operative Hypofractionated Proton Therapy No drug interventions treatment Not Available recruiting NCT03449901
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer No drug interventions treatment 2 completed NCT00626704
Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma No drug interventions treatment 1 / 2 completed NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors No drug interventions treatment 1 unknown_status NCT01106872
Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas No drug interventions treatment 1 completed NCT02890368
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides No drug interventions treatment 1 terminated NCT03890068
Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma No drug interventions treatment 2 recruiting NCT01807468
Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors No drug interventions treatment 2 unknown_status NCT01505569
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors No drug interventions other Not Available completed NCT01612481
Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma No drug interventions prevention 2 terminated NCT03514381
Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma No drug interventions treatment 4 completed NCT02910895
A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS) No drug interventions basic_science Not Available recruiting NCT05057195
Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy No drug interventions treatment Not Available recruiting NCT02784795
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT00898755
Collecting and Storing Tissue From Young Patients With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT02811523
In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma No drug interventions treatment 1 recruiting NCT04606108
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma No drug interventions treatment 2 unknown_status NCT03064243
A Phase II Study of Apatinib in STS Patients No drug interventions treatment 2 unknown_status NCT04239443
Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer No drug interventions treatment 2 unknown_status NCT02449343
Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203) No drug interventions treatment 2 / 3 unknown_status NCT04995003
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma No drug interventions treatment 1 recruiting NCT06129903
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma No drug interventions prevention Not Available recruiting NCT06216990
Metastatic or Refractory Soft Tissue Sarcomas and Metronomic Cyclophosphamide: Further Assessment of Efficacy and Safety No drug interventions Not Available Not Available completed NCT01663090
Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas No drug interventions diagnostic Not Available withdrawn NCT04032964
Dose Finding Study of L19TNF and Doxorubicin in Patients With STS No drug interventions treatment 1 active_not_recruiting NCT05747521
Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma No drug interventions treatment Not Available recruiting NCT05549921
Phase II Study of TAEST16001 in Soft Tissue Sarcoma No drug interventions treatment 2 recruiting NCT05679921
Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma No drug interventions treatment 2 not_yet_recruiting NCT00003521
Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma treatment 2 terminated NCT04897321
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) No drug interventions treatment 1 recruiting NCT04650984
A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma No drug interventions treatment 3 recruiting NCT00718484
A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma No drug interventions treatment 2 unknown_status NCT02581384
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors No drug interventions treatment 1 / 2 terminated NCT04877587
Gemcitabine With Ascorbate Including Adolescents No drug interventions treatment 0 withdrawn NCT06494787
A Phase 2 Study Using Aliya PEF Plus Pembro for Sarcoma No drug interventions treatment 2 not_yet_recruiting NCT04589754
Adriamycin and Ifosfamide Combined With Sintilimab No drug interventions treatment 2 recruiting NCT01861951
A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma No drug interventions treatment 2 completed NCT05355753
A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors No drug interventions treatment 1 / 2 terminated NCT04055753
Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma Not Available Not Available active_not_recruiting NCT01650077
Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI Criteria No drug interventions Not Available Not Available completed NCT03730077
FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas No drug interventions other 1 terminated NCT04307277
Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma No drug interventions treatment 3 recruiting NCT05697198
PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine No drug interventions Not Available Not Available recruiting NCT03944798
Surveillance AFter Extremity Tumor surgerY No drug interventions prevention Not Available recruiting NCT03725605
LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04) No drug interventions treatment 2 completed NCT01005797
Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers No drug interventions treatment 1 completed NCT02080897
Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease No drug interventions Not Available Not Available completed NCT00755261
Phase II Study of Doxorubicin and Avastin® in Sarcoma. No drug interventions treatment 2 terminated NCT06087861
5-Day Preoperative Radiation for Soft Tissue Sarcoma No drug interventions treatment 2 recruiting NCT03168061
Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma No drug interventions treatment 1 / 2 unknown_status NCT01055028
Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma No drug interventions treatment 2 terminated NCT04791228
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors No drug interventions treatment 2 recruiting NCT04126811
Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma No drug interventions treatment 2 unknown_status NCT00502411
Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma No drug interventions treatment 1 completed NCT05432193
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) No drug interventions treatment 1 active_not_recruiting NCT04483778
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults No drug interventions treatment 1 active_not_recruiting NCT01896778
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer No drug interventions basic_science Not Available completed NCT06117878
Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma No drug interventions treatment 0 recruiting NCT05718778
Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma No drug interventions treatment Not Available recruiting NCT02923778
Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery No drug interventions treatment 2 active_not_recruiting NCT03900078
Incisional Negative Pressure Wound Therapy for Resection of Soft Tissue Tumors No drug interventions treatment Not Available completed NCT01440088
A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma No drug interventions treatment 3 completed NCT04518488
Prehabilitation Soft-Tissue Sarcoma of Lower Limb No drug interventions other Not Available unknown_status NCT00038207
Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies treatment 2 completed NCT05560009
An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas No drug interventions Not Available Not Available active_not_recruiting NCT01327885
Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma No drug interventions treatment 3 completed NCT05602415
Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma No drug interventions treatment 2 recruiting NCT01140737
A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas No drug interventions treatment 2 completed NCT03375437
RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions. No drug interventions screening Not Available active_not_recruiting NCT00864032
Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall No drug interventions treatment 1 / 2 completed NCT01392352
HYPAZ: Hypertension Induced by Pazopanib No drug interventions basic_science 2 terminated NCT05116800
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma No drug interventions treatment 2 withdrawn NCT01136499
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure No drug interventions treatment 2 completed NCT06202599
Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance No drug interventions Not Available Not Available completed NCT04166006
A Phase II Study on Adjuvant Vaccination With Dendritic Cells Loaded With Autologous Tumor Homogenate in Resected Stage IV Rare Cancers. No drug interventions treatment 2 recruiting NCT01135849
B-Receptor Signaling in Cardiomyopathy No drug interventions Not Available Not Available completed NCT06514313
Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma. No drug interventions treatment 2 recruiting NCT06409013
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma No drug interventions Not Available Not Available recruiting NCT04383119
Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma No drug interventions treatment 2 recruiting NCT05597917
tTF-NGR Randomized Study - STS No drug interventions treatment 3 recruiting NCT05526417
Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma No drug interventions supportive_care Not Available recruiting NCT05224934
Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma No drug interventions treatment 2 recruiting NCT06050434
Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients No drug interventions Not Available Not Available recruiting NCT01136824
Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden No drug interventions Not Available Not Available completed NCT02367924
Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma No drug interventions Not Available Not Available completed NCT03462316
NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma No drug interventions treatment 1 active_not_recruiting NCT00179816
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors treatment 1 / 2 unknown_status NCT04811196
A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients No drug interventions treatment 1 active_not_recruiting NCT03957096
A Safety Study of SGN-CD47M in Patients With Solid Tumors No drug interventions treatment 1 terminated NCT06551896
Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor No drug interventions treatment 2 not_yet_recruiting NCT03283696
A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma No drug interventions treatment 1 completed NCT02398058
Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS) No drug interventions treatment 1 completed NCT02628535
Safety Study of MGD009 in B7-H3-expressing Tumors No drug interventions treatment 1 terminated NCT03220035
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) No drug interventions treatment 2 active_not_recruiting NCT00742963
Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma No drug interventions treatment 1 / 2 completed NCT02270086
Evaluating Bacterial Response in Sarcoma Management Using Fluorescence Imaging No drug interventions Not Available Not Available completed NCT05131386
Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas No drug interventions treatment 2 recruiting NCT02301039
SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas No drug interventions treatment 2 completed NCT00717522
Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma No drug interventions treatment 2 terminated NCT01802125
Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas No drug interventions Not Available Not Available completed NCT03719430
APX005M and Doxorubicin in Advanced Sarcoma No drug interventions treatment 2 active_not_recruiting NCT03972930
Hypofractionated Radiotherapy for Soft Tissue Sarcomas No drug interventions treatment 2 active_not_recruiting NCT04616248
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT04910126
Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma No drug interventions treatment 2 unknown_status NCT00194766
Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer treatment 2 completed NCT05684874
Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma No drug interventions diagnostic Not Available recruiting NCT06332274
tislelizUMaB in canceR Patients With molEcuLar residuaL Disease No drug interventions treatment 3 not_yet_recruiting NCT05448820
YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma No drug interventions treatment 1 / 2 active_not_recruiting NCT02659020
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma No drug interventions treatment 1 / 2 completed NCT06171282
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors No drug interventions treatment 0 recruiting NCT01819831
A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall No drug interventions treatment Not Available completed NCT00356031
Bevacizumab and Radiation Therapy for Sarcomas No drug interventions treatment 2 completed NCT03546127
Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study No drug interventions Not Available Not Available completed NCT00753727
Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma No drug interventions treatment 1 / 2 unknown_status NCT04012827
Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma No drug interventions treatment 2 unknown_status NCT02672527
Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma No drug interventions treatment 3 completed NCT05813327
Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma No drug interventions treatment 1 / 2 recruiting NCT03114527
Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) No drug interventions treatment 2 active_not_recruiting NCT02547376
Genetic and Telomere Characteristics of High of Grade Soft Tissue Sarcomas No drug interventions Not Available Not Available terminated NCT04906876
A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas No drug interventions treatment 2 withdrawn NCT03960060
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors No drug interventions treatment 1 unknown_status NCT01303094
Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma No drug interventions treatment 2 completed NCT06500091
TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors No drug interventions treatment 2 not_yet_recruiting NCT03126591
A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma No drug interventions treatment 1 completed NCT01168791
Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma No drug interventions treatment 3 completed NCT02453191
TVEC and Preop Radiation for Sarcoma (4 ml Dose) No drug interventions treatment 1 / 2 completed NCT04599062
TVEC and Preop Radiation for Sarcoma (8 ml Dose) No drug interventions treatment 1 / 2 active_not_recruiting NCT06317480
Outcomes Comparison Between Bone Resection and Subperiosteal Dissection for Specific Type of Soft Tissue Sarcoma No drug interventions Not Available Not Available completed NCT00633789
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types No drug interventions treatment 2 completed NCT00918489
Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS) No drug interventions treatment 2 completed NCT02867592
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors No drug interventions treatment 2 active_not_recruiting NCT00186992
Radiation Therapy to Treat Musculoskeletal Tumors No drug interventions treatment 2 active_not_recruiting NCT00790244
A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall No drug interventions treatment 2 unknown_status NCT05656144
Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma No drug interventions treatment 2 not_yet_recruiting NCT01719744
Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma No drug interventions treatment 2 completed NCT00441467
Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma No drug interventions treatment 2 completed NCT02712567
SARC021C: A Continuation Study of TH-CR-406/SARC021 No drug interventions Not Available Not Available no_longer_available NCT05776667
Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue Sarcoma No drug interventions treatment Not Available recruiting NCT05229601
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02527304
Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery No drug interventions treatment Not Available completed NCT00365872
External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma No drug interventions treatment 2 completed NCT03268772
PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS No drug interventions treatment 2 unknown_status NCT05563272
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors No drug interventions diagnostic 2 recruiting NCT03997968
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT05621668
A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma No drug interventions treatment 1 recruiting NCT06436846
Genomic Risk in Retroperitoneal Sarcoma No drug interventions Not Available Not Available recruiting NCT03818412
Circulating Tumor DNA in Soft Tissue Sarcoma No drug interventions other Not Available recruiting NCT02255110
A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma No drug interventions treatment 2 terminated NCT02634710
Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall No drug interventions treatment Not Available active_not_recruiting NCT03618381
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults No drug interventions treatment 1 recruiting NCT04091295
BLESSED: Expanded Access for DeltaRex-G for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast No drug interventions Not Available Not Available available NCT06413095
PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS No drug interventions basic_science 0 completed NCT03784014
Molecular Profiling of Advanced Soft-tissue Sarcomas No drug interventions health_services_research 3 active_not_recruiting NCT04577014
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma No drug interventions treatment 1 / 2 active_not_recruiting NCT06333314
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI No drug interventions treatment 2 recruiting NCT05121350
A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma No drug interventions treatment 3 unknown_status NCT01102608
Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma No drug interventions treatment 2 completed NCT03449108
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas No drug interventions treatment 2 active_not_recruiting NCT02199938
Identification and Characterization of Molecular Markers in Musculoskeletal Tumors No drug interventions Not Available Not Available terminated NCT06506838
Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma No drug interventions treatment 4 recruiting NCT02451943
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma No drug interventions treatment 3 active_not_recruiting NCT05542433
Phase II Study of Chiauranib Capsule in Advanced or Unresectable Soft Tissue Sarcoma treatment 2 recruiting NCT00385203
The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). No drug interventions treatment 2 completed NCT00276302
Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) No drug interventions treatment 1 completed NCT00423254
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. No drug interventions treatment 1 completed NCT02536183
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors treatment 1 terminated NCT00687778
11C-Acetate PET/CT Non-FDG-Avid Tumors No drug interventions Not Available Not Available unknown_status NCT04425967
Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas No drug interventions treatment Not Available recruiting NCT04506008
Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas No drug interventions treatment 2 recruiting NCT03946943
Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma No drug interventions treatment 2 unknown_status NCT05739084
Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS No drug interventions Not Available Not Available recruiting NCT01830153
RAD001 in Advanced Sarcoma No drug interventions treatment 2 completed NCT04223583
Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule No drug interventions treatment 4 completed NCT02636725
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas No drug interventions treatment 2 completed NCT02575066
Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients No drug interventions treatment 2 terminated NCT03149120
Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas No drug interventions treatment 2 withdrawn NCT00881595
Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas No drug interventions treatment 2 withdrawn NCT01962103
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors No drug interventions treatment 1 / 2 completed NCT03985722
Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients treatment 1 active_not_recruiting NCT03680430
Evaluation of Adaptive Radiation Therapy in Pre-operative or Exclusive Radiation Therapy for Limb Soft Tissues Sarcomas No drug interventions treatment Not Available unknown_status NCT02812654
Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment treatment 2 unknown_status NCT02897128
Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma No drug interventions Not Available Not Available completed NCT02464332
Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery Not Available 1 withdrawn NCT00860015
Alimta Plus Gemcitabine for Advanced Sarcoma treatment 2 completed NCT00753688
Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy No drug interventions treatment 3 completed NCT00243685
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis No drug interventions treatment 2 / 3 completed NCT00189137
Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma treatment 2 completed NCT04216953
MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma treatment 1 / 2 active_not_recruiting NCT04887298
Study of Liposomal Annamycin for the Treatment of Subjects With Soft-Tissue Sarcomas (STS) With Pulmonary Metastases treatment 1 / 2 active_not_recruiting NCT05515575
A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA treatment 2 active_not_recruiting NCT04605770
Pemetrexed, Cisplatin With Soft Tissue Sarcoma treatment 2 unknown_status NCT04673942
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors No drug interventions treatment 2 recruiting NCT05894018
Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma treatment 2 recruiting NCT06480396
High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma No drug interventions diagnostic 3 not_yet_recruiting NCT06128863
Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial treatment 2 recruiting NCT06550765
Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors No drug interventions treatment Not Available not_yet_recruiting NCT05488366
Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma treatment 0 recruiting NCT03815474
Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients treatment 2 unknown_status NCT03798795
Radiomics for Tumor Grading of Soft Tissue Sarcomas. No drug interventions Not Available Not Available completed NCT03480399
Long Term Morbidity and Quality of Life in Retroperitoneal Sarcomas No drug interventions Not Available Not Available unknown_status NCT05138146
A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma No drug interventions treatment 2 not_yet_recruiting NCT03058406
A Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas No drug interventions Not Available Not Available completed NCT02793050
Retrospective Study of Trabectedin in Soft Tissue Sarcomas No drug interventions Not Available Not Available completed NCT02808247
Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma No drug interventions treatment 2 terminated NCT02929394
Trabectedin Maintenance Post 1st-line in STS treatment 3 terminated NCT02309242
Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study No drug interventions screening Not Available unknown_status NCT02367651
Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma No drug interventions treatment 2 withdrawn NCT01995981
Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS No drug interventions Not Available Not Available completed NCT01185964
A Study of Olaratumab in Soft Tissue Sarcoma No drug interventions treatment 1 / 2 completed NCT00859456
Sunitinib in Certain Subtypes of Soft Tissue Sarcomas No drug interventions treatment 2 terminated NCT00490451
A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma No drug interventions treatment 2 completed NCT00289809
TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients No drug interventions treatment 1 / 2 completed NCT00093080
Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) treatment 2 completed NCT00142571
Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma treatment 3 completed NCT00061659
Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma treatment 2 completed NCT00079950
Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma treatment 2 suspended NCT05522257
PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas No drug interventions diagnostic Not Available recruiting NCT06263231
A Study to Investigate Efficacy & Safety of INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) treatment 3 recruiting NCT01985295
Combined Modality Treatment of Sarcomas of the Extremities No drug interventions treatment 1 completed NCT05813808
Low-dose Computer Tomography in Follow-up of Soft Tissue Sarcomas No drug interventions diagnostic Not Available completed NCT02994264
A Study to Compare Adjuvant Concurrent Chemoradiation (CCRT) to Adjuvant Radiation Therapy (RT) in Grade 2 and 3 Extremity Soft Tissue Sarcomas No drug interventions Not Available Not Available completed NCT05296564
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers No drug interventions treatment 1 / 2 recruiting NCT04219202
Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion No drug interventions treatment Not Available recruiting NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT04172805
Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma No drug interventions treatment 2 recruiting NCT04991883
Analysis of the Molecular Profile of the Mixofibrosarcoma of the Extremities No drug interventions Not Available Not Available completed NCT05851456
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors No drug interventions treatment 0 recruiting NCT05235100
Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma No drug interventions treatment 2 recruiting NCT04248959
Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas No drug interventions supportive_care Not Available completed NCT05614375
Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus No drug interventions Not Available Not Available recruiting NCT01949506
(SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas No drug interventions treatment Not Available completed NCT03600649
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas No drug interventions treatment 1 active_not_recruiting NCT06114173
Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma No drug interventions treatment 0 active_not_recruiting NCT04356872
The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma No drug interventions treatment 2 unknown_status NCT03759704
Metabolic Characteristics of Sarcoma In Vivo Using HP 13-C Magnetic Resonance Spectroscopic Imaging (MRSI) No drug interventions Not Available Not Available withdrawn NCT05193214
A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma No drug interventions treatment 2 not_yet_recruiting NCT05858710
Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma No drug interventions treatment 1 recruiting NCT02415816
Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas No drug interventions diagnostic Not Available active_not_recruiting NCT02326025
A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma No drug interventions basic_science 1 completed NCT02275286
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients No drug interventions treatment 1 / 2 recruiting NCT01491594
Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia No drug interventions prevention 1 terminated NCT00406601
BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas No drug interventions treatment 2 completed NCT00297258
Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma No drug interventions treatment 2 completed NCT00204646
Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) No drug interventions treatment 2 completed NCT00204568
Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS) treatment 2 unknown_status NCT00204620
Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS) No drug interventions treatment 2 completed NCT00187174
Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors treatment 1 completed NCT00130858
a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4 treatment 2 completed NCT00134641
Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas treatment 2 completed NCT06408441
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN) No drug interventions Not Available Not Available recruiting NCT04347122
Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction No drug interventions treatment 4 completed NCT05167994
Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma No drug interventions treatment 2 unknown_status NCT04595994
Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma No drug interventions treatment 1 recruiting NCT03474094
Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy No drug interventions treatment 2 recruiting NCT05612191
Catequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial) No drug interventions Not Available Not Available available NCT06074692
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA) No drug interventions treatment 2 recruiting NCT06114004
Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc) No drug interventions treatment 2 recruiting NCT04122872
GISAR German Interdisciplinary Sarcoma Registry No drug interventions Not Available Not Available recruiting